ODAC Decides All Thumbs Way Down for Abraxane Because...

ODAC Decides All Thumbs Way Down for Abraxane Because Sponsor Requests to Omit Randomized Trial

Fromer, Margot J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
28
Language:
english
Journal:
Oncology Times
DOI:
10.1097/01.cot.0000303889.15497.94
Date:
September, 2006
File:
PDF, 73 KB
english, 2006
Conversion to is in progress
Conversion to is failed